— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.7% 1M: -18.2% 3M: +13.9% YTD: +46.9% 1Y: +210.4% 3Y: -21.3% 5Y: -59.5%
$13.07
-0.38 (-2.83%)
 
Weekly Expected Move ±6.5%
$11 $12 $13 $14 $15
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $1.1B mcap · 79M float · 5.95% daily turnover · Short 56% of daily vol

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-08-03
Earliest Filing
2025-03-07
Latest Filing
investor: 2 partner: 1

Counterparties (Filed by REPL)

3 relationships

Companies named in REPL's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
667, L.P. — investor Investor in private placement and public offering; counterparty to registration rights agreement. 2025-03-07 View
Baker Brothers Life Sciences, L.P. — investor Investor in private placement and public offering; counterparty to registration rights agreement. 2025-03-07 View
Leerink Partners LLC — partner Sales agent for the Company's at-the-market offering program 2023-08-03 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-16 Bylaws Amendment; Shareholder Vote; Exhibits View
2026-08-14 Earnings Release; Exhibits View
2026-08-11 Other Events; Exhibits View
2026-08-10 Other Events; Exhibits View
2026-08-07 Other Events; Exhibits View
2026-07-31 Other Events; Exhibits View
2026-07-30 Regulation FD; Exhibits View
2026-06-29 Earnings Release; Exhibits View
2026-06-26 Regulation FD; Exhibits View
2026-05-29 Regulation FD; Exhibits View
2026-04-13 Regulation FD; Other Events; Exhibits View
2026-02-03 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of Agreement View
2026-01-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-11-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-20 Other Events; Financial Statements and Exhibits View
2025-09-18 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-09-04 Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure; Financial Statements View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-22 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-06-24 Regulation FD Disclosure View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms